LYRA - Lyra Therapeutics Inc
1.2783
-0.012 -0.915%
Share volume: 14,714
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.29
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 04-30-2024 | 08-14-2024 | 11-12-2024 | 03-13-2025 | 05-06-2025 | 11-12-2025 | |
| Assets | |||||||
| Total Assets | 141.527 M | 94.582 M | 78.756 M | 66.346 M | 56.316 M | 43.709 M | |
| Current Assets | 89.443 M | 69.435 M | 54.444 M | 43.025 M | 33.905 M | 23.019 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 71.319 M | 35.593 M | 27.826 M | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 15.799 M | 31.905 M | 23.800 M | 40.577 M | 31.735 M | 22.055 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.783 M | 1.665 M | 1.613 M | 1.404 M | 1.276 M | 1.122 M | |
| Other Assets | 48.301 M | 23.482 M | 22.699 M | 21.917 M | 21.135 M | 19.568 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 141.527 M | 94.582 M | 78.756 M | 66.346 M | 56.316 M | 43.709 M | |
| Total liabilities | 64.023 M | 63.605 M | 58.137 M | 54.752 M | 52.444 M | 48.037 M | |
| Total current liabilities | 18.724 M | 19.276 M | 14.954 M | 12.631 M | 11.470 M | 9.480 M | |
| Accounts Payable | 2.844 M | 4.971 M | 2.292 M | 1.179 M | 725.000 K | 627.000 K | |
| Other liabilities | 33.356 M | 32.479 M | 31.321 M | 30.259 M | 29.113 M | 26.695 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 33.356 M | 32.479 M | 31.321 M | 30.259 M | 29.113 M | 26.695 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 77.504 M | 30.977 M | 20.619 M | 11.594 M | 3.872 M | -4.328 M | |
| Common stock | 411.286 M | 412.919 M | 414.410 M | 416.384 M | 417.209 M | 422.430 M | |
| Retained earnings | -333.807 M | -381.938 M | -393.811 M | -404.790 M | -413.337 M | -426.758 M |